Armed with Pfizer’s ADC Platform, Pyxis Scores $152M Round to Shoot for the Clinic while Taking its Time on I/O Programs April 2, 2021
Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics March 30, 2021
Pfizer ships out 2 cancer ADCs alongside its tech platform to Pyxis Oncology, and its familiar CEO March 25, 2021
Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates March 25, 2021
